TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver Cancer
Clinical trial NCT05550025 · UNKNOWN
Trial details
- NCT number
- NCT05550025
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-17
- Primary completion
- 2023-11-11
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.